FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults.

MONDAY, Oct. 28, 2024 -- Repeated concussions dramatically increase a hockey player’s risk of depression and burnout, a new study warns. Hockey...

MONDAY, Nov. 4, 2024 -- Women who’ve had concussions are more likely to suffer severe mental health problems following childbirth, a new study...

FRIDAY, Oct. 24, 2024 -- Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

MONDAY, Nov. 4, 2024 -- Menopausal women with frequent hot flashes and night sweats are more likely to develop type 2 diabetes, a new study...

Compared to other diabetes medications, semaglutide might offer added protection against Alzheimer's for type 2 diabetes patients.

WEDNESDAY, Oct. 23, 2024 -- Long-term exposure to even low levels of arsenic in drinking water can raise a person’s risk of heart disease, a new...